Is age alone suitable screening for cardiovascular preventive treatment?

European Heart Journal

Volumn 32, Issue 20, 2011, Pages 2470-2471

  Jaques, Helen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; GROUPS BY AGE; HEALTH CARE COST; HEART INFARCTION; HUMAN; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; SCREENING TEST; STROKE; DRUG FORMULATION; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; PILL; POLYPILL; SECONDARY PREVENTION;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; HUMANS; MIDDLE AGED; POLYPHARMACY; TABLETS;

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; RAMIPRIL; SIMVASTATIN; THIAZIDE DIURETIC AGENT;

EID: 80054746499     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr318     Document Type: Note

References (3)

1. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419.
2. Wald NJ, Simmonds M, Morris JK. Screening for future cardiovascular disease using age alone compared with multiple risk factors and age. PLoS ONE 2011;6:e18742.
3. Wald NJ, Wald DS. The polypill concept. Heart 2010;96:1-4.